Tags |
|
|
Links |
|
|
Digg It - Outsourcing Vs. Outsourcing
Maybe it is something that I have been hearing about in the news or perha
According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product
ps something I have discovered during my four year freelance career: outs
; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.
Examples of combination products may in
Examples of combination products may in
ourcing is a *big issue* for everyone both for Americans who are affected
lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.
by this practice and by those workers peddling their wares.
Lately, I ha
Lately, I ha
here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe
ve been turning down jobs left and right when it is clear that the employ
d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.
Combination pro
Combination pro
ers want nothing more than ultra cheap labor. I suppose the proliferation
ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc
of $3 per article writers from India and elsewhere has emboldened some pe
easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi
ople to produce proposals geared toward that segment of the writing indus
nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically
try. Let’s face it: few Americans I know can afford to work for chump cha
and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ
ge.
On the other hand, I have had the opportunity to outsource some of m
On the other hand, I have had the opportunity to outsource some of m
ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi
y projects as well. Instead of going to the article mills, I have been wo
ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.
Following aspects would a
Following aspects would a
rking with an author or two experienced in writing on subjects I know lit
dd to the challenges in developing combination products:
Which markets to tap where the combination products can do fairly well?
Which combination prod
Which markets to tap where the combination products can do fairly well?
Which combination prod
le about including pet care, beauty products, and more. My plan for these
cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin
authors is to pay them the full rate minus any processing charge I must
tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
What would be the developing cost?
How to tackle the risks encountered during combination product developmen
pick up. I figure that means about $1-5 subtracted from the cost of a $50
t?
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel
article; if they are good at what they do I’ll simply eat that cost.
I k
I k
ping new procedures for reviewing their safety, efficacy and quality.
Professional from academic institutions, pharmaceutical industries, health care indust
Professional from academic institutions, pharmaceutical industries, health care indust
now that I am mostly preaching to the choir when I state all of this, but
y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products
it is worth a repeat: pay your people what they are worth and you will g
.
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de
t superior and unrivaled writing that can only enhance your business. Set
elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.
Companies that provide selfless information through particip
Companies that provide selfless information through particip
tle for less and your business will reflect the shoddiness that you chose
tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products
HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.diggit.org.ua/article/32695/diggit-Outsourcing-Vs-Outsourcing.html">Outsourcing Vs. Outsourcing</a>
BB link (for phorums):
[url=http://www.diggit.org.ua/article/32695/diggit-Outsourcing-Vs-Outsourcing.html]Outsourcing Vs. Outsourcing[/url]
Related Articles:
How to Use Color and Graphics in Your Business Proposals
Acting - My Future Stage Career
Bookmark it:
|